SciCombinator

Discover the most talked about and latest scientific content & concepts.

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

OPEN BMJ (Clinical research ed.) | 16 May 2020

W Tang, Z Cao, M Han, Z Wang, J Chen, W Sun, Y Wu, W Xiao, S Liu, E Chen, W Chen, X Wang, J Yang, J Lin, Q Zhao, Y Yan, Z Xie, D Li, Y Yang, L Liu, J Qu, G Ning, G Shi and Q Xie
Abstract
To assess the efficacy and safety of hydroxychloroquine plus standard of care compared with standard of care alone in adults with coronavirus disease 2019 (covid-19).
Tweets*
5505
Facebook likes*
10
Reddit*
3
News coverage*
163
Blogs*
11
SC clicks
1
Concepts
-
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com